Terms: = Brain cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
1195 results:
1. Curcumin affects autophagy of prolactinoma cells by upregulating miR-206 to exert antitumor effects.
Duan JF; Zhang QJ; Zhu J; Lu JH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23734. PubMed ID: 38764151
[TBL] [Abstract] [Full Text] [Related]
2. YANK2 activated by Fyn promotes glioma tumorigenesis via the mtor-independent p70S6K activation pathway.
Shi Y; Cheng Y; Wang W; Tang L; Li W; Zhang L; Yuan Z; Zhu F; Duan Q
Sci Rep; 2024 May; 14(1):10507. PubMed ID: 38714727
[TBL] [Abstract] [Full Text] [Related]
3. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
[TBL] [Abstract] [Full Text] [Related]
4. The
Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
[TBL] [Abstract] [Full Text] [Related]
5. Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1.
Ren X; Deng D; Xiang S; Feng J
Aging (Albany NY); 2024 Apr; 16(8):7174-7187. PubMed ID: 38669103
[TBL] [Abstract] [Full Text] [Related]
6. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mtor dual inhibitor.
Wang S; Zhang D; Wang J; Peng X; Sun H; Ji Y; Yang Z; Bian X; Hou Y; Ge M; Liu Y
J Neurooncol; 2024 May; 168(1):139-149. PubMed ID: 38662151
[TBL] [Abstract] [Full Text] [Related]
7. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
8. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mtor pathway to inhibit nasopharyngeal carcinoma metastasis.
Xu M; Fan Y; Zou G; Yang Q; Xu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
[TBL] [Abstract] [Full Text] [Related]
9. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors.
Cheng Y; Dai Y; Tang H; Lu X; Xie J; Xie W; Zhang Q; Liu Y; Lin S; Yao H; Shang H; Yang K; Liu H; Wu X; Zhang J; Zhang X; Xue L; Wu ZB
Acta Neuropathol Commun; 2024 Apr; 12(1):61. PubMed ID: 38637883
[TBL] [Abstract] [Full Text] [Related]
11. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.
Dundar B; Alsawas M; Masaadeh A; Conway K; Snow AN; Sompallae RR; Bossler AD; Ma D; Lopes Abath Neto O
Pathol Res Pract; 2024 May; 257():155272. PubMed ID: 38631135
[TBL] [Abstract] [Full Text] [Related]
12. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
[TBL] [Abstract] [Full Text] [Related]
13. Cerebellar phenotypes in germline PTEN mutation carriers.
Gambini D; Ferrero S; Bulfamante G; Pisani L; Corbo M; Kuhn E
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12970. PubMed ID: 38504418
[TBL] [Abstract] [Full Text] [Related]
14. Just a spoonful of metformin helps the medicine go down.
Tzaridis T; Wechsler-Reya RJ
J Clin Invest; 2024 Mar; 134(6):. PubMed ID: 38488006
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
[TBL] [Abstract] [Full Text] [Related]
16. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
[TBL] [Abstract] [Full Text] [Related]
17. Effect of gold-conjugated resveratrol nanoparticles on glioma cells and its underlying mechanism.
Liu X; Guo Z; Li J; Wu D; Liu Z; Guan C; Guan Y; Lu X
Biomed Mater Eng; 2024; 35(3):279-292. PubMed ID: 38461500
[TBL] [Abstract] [Full Text] [Related]
18. Daurisoline suppress glioma progression by inhibiting autophagy through PI3K/AKT/mtor pathway and increases TMZ sensitivity.
Yin HT; Hui-Lu ; Yang JH; Li Q; Li M; Zhao QQ; Wen ZP
Biochem Pharmacol; 2024 May; 223():116113. PubMed ID: 38460907
[TBL] [Abstract] [Full Text] [Related]
19. Effectively α-Terpineol Suppresses Glioblastoma Aggressive Behavior and Downregulates KDELC2 Expression.
Jin JS; Chou JM; Tsai WC; Chen YC; Chen Y; Ong JR; Tsai YL
Phytomedicine; 2024 May; 127():155471. PubMed ID: 38452695
[TBL] [Abstract] [Full Text] [Related]
20. Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities.
Ezzati S; Salib S; Balasubramaniam M; Aboud O
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396993
[TBL] [Abstract] [Full Text] [Related]
[Next]
